Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Recombinant Lysozyme Derived From Plants

By HospiMedica staff writers
Posted on 13 Mar 2006
A recombinant human lysozyme has been produced in an animal-free system. More...
The bacterial-cell lysis agent can be used in diagnostic applications, bioprocessing, and life science research.

The lysozyme has many advantages over other lysing agents. Because it is produced in an animal-free system, it is free of infectious viral or prion contaminants. Prions are the causative agent of bovine spongiform encephalopathy (BSE), or mad cow disease. The lysozyme outperforms chicken lysozyme, a common animal-derived cell lysis agent, and is four times more active per mg for lysing Micrococcus and E coli. Lysobac, the lysozyme produced by Ventria Bioscience (Sacramento, CA, USA), is available in packages of 100 million, 10 billion, and 100 billion.

Lysobac is a recombinant protein that provides consistent cell lysis results so that process changes are minimized. For bioprocessing applications, it saves time by eliminating steps in the production process because it enables in-culture protein extraction. In addition, Lysobac is highly active and therefore it adds minimal volume to the final extract. It is cheaper than chicken lysozyme because of its high activity and efficient production methods. Lysobac is a gentle lysing agent providing minimal risk of denaturing the protein product.



Related Links:
Ventria

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gynecological Examination Chair
arco-matic
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.